FBRX – Forte Biosciences Inc
Forte Biosciences, Inc.FBRX
$14.08Name : Forte Biosciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $175,054,576.00
EPSttm : -3.68
Forte Biosciences, Inc.
$14.08
0.00%$0.0000Float Short %
4.46
Margin Of Safety %
Put/Call OI Ratio
0.82
EPS Next Q Diff
-0.08
EPS Last/This Y
7.74
EPS This/Next Y
1.11
Price
14.06
Target Price
63.33
Analyst Recom
1
Performance Q
18.22
Relative Volume
0.51
Beta
3.26
Ticker: FBRX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | FBRX | 12.19 | 8.25 | 0.00 | 37 |
| 2025-10-21 | FBRX | 11.7 | 0.89 | 0.00 | 70 |
| 2025-10-22 | FBRX | 11.54 | 0.89 | 0.00 | 70 |
| 2025-10-23 | FBRX | 12.09 | 0.89 | 0.00 | 70 |
| 2025-10-24 | FBRX | 12.13 | 0.58 | 999.99 | 90 |
| 2025-10-27 | FBRX | 12.95 | 0.58 | 999.99 | 90 |
| 2025-10-28 | FBRX | 13.46 | 0.58 | 999.99 | 90 |
| 2025-10-29 | FBRX | 14.22 | 0.58 | 999.99 | 90 |
| 2025-10-30 | FBRX | 13.25 | 0.60 | 0.00 | 91 |
| 2025-10-31 | FBRX | 12.83 | 0.60 | 0.00 | 91 |
| 2025-11-03 | FBRX | 11.65 | 0.60 | 0.00 | 91 |
| 2025-11-04 | FBRX | 10.99 | 0.60 | 0.00 | 91 |
| 2025-11-05 | FBRX | 10.31 | 0.60 | 0.00 | 91 |
| 2025-11-06 | FBRX | 11.55 | 0.60 | 0.00 | 91 |
| 2025-11-07 | FBRX | 12.22 | 0.44 | 0.00 | 111 |
| 2025-11-10 | FBRX | 13.55 | 0.43 | 0.00 | 113 |
| 2025-11-11 | FBRX | 13.91 | 0.43 | 0.00 | 113 |
| 2025-11-12 | FBRX | 14.43 | 0.43 | 999.99 | 113 |
| 2025-11-13 | FBRX | 14.12 | 0.68 | 999.99 | 133 |
| 2025-11-14 | FBRX | 14.42 | 0.82 | 7.50 | 144 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | FBRX | 12.19 | 76.5 | - | -4.43 |
| 2025-10-21 | FBRX | 11.79 | 76.5 | - | -4.43 |
| 2025-10-22 | FBRX | 11.66 | 76.5 | - | -4.43 |
| 2025-10-23 | FBRX | 12.14 | 76.5 | - | -4.43 |
| 2025-10-24 | FBRX | 12.15 | 76.5 | - | -4.43 |
| 2025-10-27 | FBRX | 12.98 | 76.5 | - | -4.43 |
| 2025-10-28 | FBRX | 13.46 | 76.5 | - | -4.43 |
| 2025-10-29 | FBRX | 14.39 | 76.5 | - | -4.43 |
| 2025-10-30 | FBRX | 13.27 | 76.5 | - | -4.43 |
| 2025-10-31 | FBRX | 12.94 | 76.5 | - | -4.43 |
| 2025-11-03 | FBRX | 11.68 | 76.5 | - | -4.43 |
| 2025-11-04 | FBRX | 11.02 | 76.5 | - | -4.43 |
| 2025-11-05 | FBRX | 10.62 | 76.5 | - | -4.43 |
| 2025-11-06 | FBRX | 11.43 | 76.5 | - | -4.43 |
| 2025-11-07 | FBRX | 12.08 | 76.5 | - | -4.43 |
| 2025-11-10 | FBRX | 13.67 | 76.5 | - | -4.43 |
| 2025-11-11 | FBRX | 14.09 | 76.5 | - | -4.43 |
| 2025-11-12 | FBRX | 14.45 | 76.5 | - | -4.43 |
| 2025-11-13 | FBRX | 13.95 | 76.5 | - | -4.43 |
| 2025-11-14 | FBRX | 14.06 | 76.5 | - | -4.43 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | FBRX | 0.00 | 44.93 | 1.63 |
| 2025-10-21 | FBRX | 0.00 | 44.93 | 1.63 |
| 2025-10-22 | FBRX | 0.00 | 44.93 | 1.63 |
| 2025-10-23 | FBRX | 0.00 | 44.93 | 1.63 |
| 2025-10-24 | FBRX | 0.00 | 44.93 | 1.63 |
| 2025-10-27 | FBRX | 0.00 | 47.48 | 2.46 |
| 2025-10-28 | FBRX | 0.00 | 47.48 | 2.46 |
| 2025-10-29 | FBRX | 0.00 | 47.48 | 2.46 |
| 2025-10-30 | FBRX | 0.00 | 47.48 | 2.46 |
| 2025-10-31 | FBRX | 0.00 | 47.48 | 2.46 |
| 2025-11-03 | FBRX | 0.00 | 44.94 | 2.46 |
| 2025-11-04 | FBRX | 0.00 | 44.94 | 2.46 |
| 2025-11-05 | FBRX | 0.00 | 44.94 | 2.46 |
| 2025-11-06 | FBRX | 0.00 | 44.94 | 2.46 |
| 2025-11-07 | FBRX | 0.00 | 44.94 | 2.46 |
| 2025-11-10 | FBRX | 0.00 | 44.30 | 2.46 |
| 2025-11-11 | FBRX | 0.00 | 44.30 | 2.46 |
| 2025-11-12 | FBRX | 0.00 | 44.30 | 4.46 |
| 2025-11-13 | FBRX | 0.00 | 44.30 | 4.46 |
| 2025-11-14 | FBRX | 0.00 | 44.30 | 4.46 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.96
Avg. EPS Est. Current Quarter
-1.07
Avg. EPS Est. Next Quarter
-1.04
Insider Transactions
Institutional Transactions
44.3
Beta
3.26
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
9
Growth Score
19
Sentiment Score
91
Actual DrawDown %
98.7
Max Drawdown 5-Year %
-99.6
Target Price
63.33
P/E
Forward P/E
PEG
P/S
P/B
1.75
P/Free Cash Flow
EPS
-7.99
Average EPS Est. Cur. Y
-4.43
EPS Next Y. (Est.)
-3.33
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.51
Return on Equity vs Sector %
-69.9
Return on Equity vs Industry %
-55.2
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.05
EBIT Estimation
Forte Biosciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 14
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading